Project UpdateJul 31, 2026, 08:05 AM
Picard Medical Unveils Emperor Total Artificial Heart Architecture
AI Summary
Picard Medical, Inc. announced a major milestone in its Emperor Total Artificial Heart (TAH) program with the first public scientific presentation of its integrated architecture. The presentation at the IEEE EMBC 2026 detailed how the patent-pending Emperor Drive System (EDS) integrates with the SynCardia Total Artificial Heart (STAH) ventricles. This development represents a significant step towards a next-generation, fully implantable artificial heart, building on the STAH's clinical foundation.
Key Highlights
- Picard Medical presented the integrated Emperor Total Artificial Heart (TAH) architecture at IEEE EMBC 2026.
- The Emperor TAH combines clinically proven SynCardia TAH ventricles with the new Emperor Drive System (EDS).
- The EDS is a compact electromechanical driver designed to replace current pneumatic drivers.
- This development aims to advance the platform toward future full implantability.
- The SynCardia TAH has supported over 2,100 patients worldwide.
- The SynCardia TAH remains the only FDA-approved, commercially available total artificial heart in the U.S.
Price Impact
More from PMI